Zhejiang Innoforce Pharmaceuticals
PrivateLast Round
Series A
Dec 6, 2021
Total Funding Raised
$156.6M
Company Overview
Zhejiang Innoforce Pharmaceuticals is a biopharmaceutical company that provides end-to-end contract development and manufacturing services (CDMO), including GMP manufacturing of RNA, plasmid DNA, viral vectors, and cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Pharma Supply Chain, Precision Medicine, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zhejiang Innoforce Pharmaceuticals Comparables
Compare Zhejiang Innoforce Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| uBriGene Biosciences | 91% | |
| OBiO Technology | 84% | |
| GenScript | 83% | |
Zhejiang Innoforce Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 6, 2021 | ||||
| VC Round | Jun 1, 2020 |
Key People
Founding team and executive leadership
Zhejiang Innoforce Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CCIC Capital | Series A |
| Triwise Capital | Series A |
| 中南创投基金 | Series A |
| Advantech Capital | Series A |
| Quan Capital | Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors grew 650% MoM, reaching 885.
- Dec 6, 2021
$157M round led by 中南创投基金
Zhejiang Innoforce Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zhejiang Innoforce Pharmaceuticals's valuation, stock price, and market status.